Estimation of absolute oral bioavailability of moxidectin in dogs using a semi-simultaneous method: Influence of lipid co-administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 5, 2007, Pages 375-380

  Lallemand, E ^a   Lespine, A ^b   Alvinerie, M ^b   Bousquet Melou, A ^a   Toutain, P L ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORN OIL; CYDECTINE; LIPID; MOXIDECTIN; UNCLASSIFIED DRUG;

ARTICLE; BODY CONSTITUTION; DISTRIBUTION VOLUME; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HALF LIFE TIME; MALE; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTHELMINTICS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CORN OIL; DOGS; FEMALE; INFUSIONS, INTRAVENOUS; MACROLIDES; MALE;

CANIS FAMILIARIS; ZEA MAYS;

EID: 34548428278     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00878.x     Document Type: Article

References (13)

1. 14C-labeled moxidectin in horses. Journal of Agricultural and Food Chemistry, 45, 3627 3633.
2. Alvinerie, M., Sutra, J.F., Badri, M. Galtier, P. (1995) Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection. Journal of Chromatography B, 674, 119 124.
3. Bassissi, M.F., Lespine, A. Alvinerie, M. (2004) Enhancement of oral moxidectin bioavailability in rabbits by lipid co-administration. Parasitology Research, 94, 188 192.
4. Bousquet-Melou, A., Mercadier, S., Alvinerie, M. Toutain, P.L. (2004) Endectocide exchanges between grazing cattle after pour-on administration of doramectin, ivermectin and moxidectin. International Journal for Parasitology, 34, 1299 1307.
5. Charman, W.N., Porter, C.J., Mithani, S. Dressman, J.B. (1997) Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. Journal of Pharmaceutical Sciences, 86, 269 282.
6. Cotreau, M.M., Warren, S., Ryan, J.L., Fleckenstein, L., Vanapalli, S.R., Brown, K.R., Rock, D., Chen, C.Y. Schwertschlag, U.S. (2003) The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans. Journal of Clinical Pharmacology, 43, 1108 1115.
7. Karlsson, M.O. Bredberg, U. (1990) Bioavailability estimation by semisimultaneous drug administration: a Monte Carlo simulation study. Journal of Pharmacokinetics and Biopharmaceutics, 18, 103 120.
8. Laffont, C.M., Bousquet-Melou, A., Bralet, D., Alvinerie, M., Fink-Gremmels, J. Toutain, P.L. (2003) A pharmacokinetic model to document the actual disposition of topical ivermectin in cattle. Veterinary Research, 34, 445 460.
9. McKellar, Q.A. Benchaoui, H.A. (1996) Avermectins and mylbemycins. Journal of Veterinary Pharmacology and Therapeutics, 19, 331 351.
10. Sundlof, S.F. (2004) Important Drug Information about ProHearth® 6 [on line]. Available at: http://www.fda.gov/cvm/proheart6091304.html.
11. Toutain, P.L. Bousquet-Mélou, A. (2004) Plasma terminal half-life. Journal of Veterinary Pharmacology and Therapeutics, 27, 427 439.
12. Vanapalli, S.R., Hung, Y.P., Fleckenstein, L., Dzimianski, M.T. McCall, J.W. (2002) Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs. Biopharmaceutics and Drug Disposition, 23, 263 272.
13. Wagner, J.G. (1993) Pharmacokinetics for the Pharmaceutical Scientist. Technomic Publishing Company, Lancaster, 336 p.